Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning.

@article{Raiola2013UnmanipulatedHB,
  title={Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning.},
  author={Anna Maria Raiola and Alida Dominietto and Anna Ghiso and Carmen di Grazia and Teresa Lamparelli and Francesca Gualandi and Stefania Bregante and Maria Teresa van Lint and Simona Geroldi and Silvia Luchetti and Filippo Ballerini and Maurizio Miglino and Riccardo Varaldo and Andrea Bacigalupo},
  journal={Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation},
  year={2013},
  volume={19 1},
  pages={
          117-22
        }
}
Fifty patients with high-risk hematologic malignancies, underwent an unmanipulated haploidentical bone marrow transplantation (BMT), followed by posttransplantation high-dose cyclophosphamide (PT-CY): the myeloablative (MA) conditioning consisted of thiotepa, busulfan, fludarabine (n = 35), or total body irradiation (TBI), fludarabine (n = 15). The median age was 42 years (range, 18-66 years); 23 patients were in remission, 27 had active disease, and 10 patients were receiving a second… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 121 CITATIONS, ESTIMATED 52% COVERAGE

Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor.

  • Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • 2018
VIEW 2 EXCERPTS

Haploidentical Stem Cell Transplantation in Adult Haematological Malignancies

  • Advances in hematology
  • 2016
VIEW 8 EXCERPTS
CITES RESULTS & BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2013
2019

CITATION STATISTICS

  • 8 Highly Influenced Citations

  • Averaged 18 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 24 REFERENCES

Rituximab treatment for Epstein-Barr virus DNAemia after alternative-donor hematopoietic stem cell transplantation.

  • Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • 2011

grafts

SM Luger, O Ringdén, MJ Zhang
  • 2011